510(k) Report

510(k) · Cleared

Cleared

HANAROSTENT Esophagus Asymmetric (CCC)

K213251510(k) SpecialCleared Nov 18, 202149-day reviewClass II21 CFR 878.3610

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

M.I.Tech Co., Ltd. · ESW Prosthesis, Esophageal

Cleared on Nov 18, 2021 as substantially equivalent to K201160 (M.I.Tech Co., Ltd., 2021) after a 49-day review. Its family tree reaches back 7 generations to 1995.

Decided
Nov 18, 2021
Review
49 days
Class
Class II
Product code
ESW
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K925406 (1995). 19 ancestors in all, the oldest K940838 (1994). No later device cites it as a predicate yet.

  1. Root · 7 generations backK925406 Biliary Endoprostheses W/Unistep Delivery SystemSchneider Intl., Ltd. · 1995
  2. 6 generations backK962899 Ultraflex DiamondBoston Scientific Corp · 1997
  3. 5 generations backK012883 Ultraflex Esophageal Stent System, Ultraflex Diamondbiliary Stent…Boston Scientific Corp · 2001 · Recalled
  4. 4 generations backK073266 Wallflex Partially Covered Esophageal Stent SystemBoston Scientific Corp · 2008
  5. 3 generations backK091510 Wallflex Esophageal Fully Covered Stent System, Models M00516700…Boston Scientific Corporation · 2009
  6. 2 generations backK172813 Esophageal Stent SystemMicro-Tech (Nanjing) Co., Ltd. · 2018
  7. 1 generation backK201160 HANAROSTENT Esophagus (CCC), HANAROSTENT Esophagus (NCN)M.I.Tech Co., Ltd. · 2021
  8. This deviceK213251 HANAROSTENT Esophagus Asymmetric (CCC)M.I.Tech Co., Ltd. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K925406Biliary Endoprostheses W/Unistep Delivery SystemSchneider Intl., Ltd.1995—
−6K962899Ultraflex DiamondBoston Scientific Corp1997—
−5K012883Ultraflex Esophageal Stent System, Ultraflex Diamondbiliary Stent System…Boston Scientific Corp200146
−4K073266Wallflex Partially Covered Esophageal Stent SystemBoston Scientific Corp2008—
−3K091510Wallflex Esophageal Fully Covered Stent System, Models M00516700, M00516710…Boston Scientific Corporation2009—
−2K172813Esophageal Stent SystemMicro-Tech (Nanjing) Co., Ltd.2018—
−1K201160HANAROSTENT Esophagus (CCC), HANAROSTENT Esophagus (NCN)M.I.Tech Co., Ltd.2021—
0 (this device)K213251HANAROSTENT Esophagus Asymmetric (CCC)M.I.Tech Co., Ltd.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199620
200010
200110
200330
200410
200510
200810
FIG. 1 — Lineage of K213251, 1995–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ESW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new ESW device

  1. #1 K261978 WallFlex Esophageal Stent System;Agile…score 15.3 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K201160HANAROSTENT Esophagus (CCC), HANAROSTENT Esophagus (NCN)
Summary page 5
…STENT® Esophagus (CCC) Applicant: M.I.Tech Co., Ltd. 510(k) Number: K201160 Clearance Date: July 23, 2021 Device:…
M.I.Tech Co., Ltd.2021—
†K091510Wallflex Esophageal Fully Covered Stent System, Models M00516700, M00516710, M00516720…Boston Scientific Corporation2009—
†K955347UltraflexBoston Scientific Corp1996—

Also cleared against K201160: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 5 companies; a new generation was cleared every 3.2 years on median.
  • 4 of the 19 ancestors have a recall of any class.
  • 1 other device also cites its predicate K201160.

How does its category compare?

All ESW devices

ESW Prosthesis, Esophageal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · ESW

3in 2025

2008: 52009: 32010: 32011: 12012: 22013: 22016: 12018: 22019: 12020: 12021: 42022: 12024: 42025: 32026 (partial year): 1
2007high 5 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ESW

90in 2025

2008: 99 days median2009: 35 days median2010: 206 days median2021: 139 days median2024: 130 days median2025: 90 days median
2007high 206 (2010) · low 35 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · ESW

25in 2010

2010: 25
2007high 25 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · ESW

120in 2025

2007: 882008: 1532009: 2392010: 2552011: 1402012: 1212013: 1452014: 1692015: 1752016: 1532017: 872018: 862019: 1672020: 1552021: 772022: 1092023: 1552024: 1662025: 120
2007high 255 (2010) · low 77 (2021)2025

MAUDE reports naming product code ESW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—088
20085990153
20093350239
2010320625255
20111—0140
20122—0121
20132—0145
20140—0169
20150—0175
20161—0153
20170—087
20182—086
20191—0167
20201—0155
20214139077
20221—0109
20230—0155
202441300166
20253900120
20261—0—

What is it indicated for?

The HANAROSTENT® Esophagus Asymmetric (CCC) is intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistula.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K213251: HANAROSTENT Esophagus Asymmetric (CCC).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K213251

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026